118 related articles for article (PubMed ID: 15997118)
1. Comparison of the inhibitory effects of docosahexaenoic acid (DHA) on U46619- and phenylephrine-induced contractions in guinea-pig aorta.
Otsuka K; Tanaka Y; Tanaka H; Koike K; Shigenobu K
Biol Pharm Bull; 2005 Jul; 28(7):1298-300. PubMed ID: 15997118
[TBL] [Abstract][Full Text] [Related]
2. Selective and potent inhibitory effect of docosahexaenoic acid (DHA) on U46619-induced contraction in rat aorta.
Sato K; Chino D; Kobayashi T; Obara K; Miyauchi S; Tanaka Y
J Smooth Muscle Res; 2013; 49():63-77. PubMed ID: 24304639
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic Acid Selectively Suppresses U46619- and PGF
Obara K; Inaba R; Kawakita M; De Dios Regadera M; Uetake T; Murata A; Nishioka N; Kuroki K; Yoshioka K; Tanaka Y
Biol Pharm Bull; 2022; 45(2):240-244. PubMed ID: 35110511
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characteristics of the inhibitory effects of docosahexaenoic acid on vascular contractions studied in rat mesenteric artery.
Sato K; Chino D; Sugimoto T; Kanai K; Obara K; Miyauchi S; Tanaka Y
Pharmacology; 2014; 93(5-6):229-43. PubMed ID: 25012911
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor-dependent contractions of guinea pig gastric fundus smooth muscle.
Xu K; Shimizu M; Murai C; Fujisawa M; Ito D; Saitoh N; Nakagome Y; Yamashita M; Murata A; Oikawa S; Ou G; Yoshioka K; Obara K; Tanaka Y
Pharmacol Res Perspect; 2022 Jun; 10(3):e00952. PubMed ID: 35466586
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid inhibits U46619- and prostaglandin F
Yoshioka K; Obara K; Oikawa S; Uemura K; Yamaguchi A; Fujisawa K; Hanazawa H; Fujiwara M; Endoh T; Suzuki T; De Dios Regadera M; Ito D; Ou G; Xu K; Tanaka Y
Eur J Pharmacol; 2021 Oct; 908():174371. PubMed ID: 34329614
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evidence showing significant roles for potassium channels and CYP epoxygenase metabolites in the relaxant effects of docosahexaenoic acid on the rat aorta contracted with U46619.
Sato K; Chino D; Nishioka N; Kanai K; Aoki M; Obara K; Miyauchi S; Tanaka Y
Biol Pharm Bull; 2014; 37(3):394-403. PubMed ID: 24369179
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the involvement of protein kinase C in agonist-induced contractions in mouse aorta and corpus cavernosum.
Jin L; Teixeira CE; Webb RC; Leite R
Eur J Pharmacol; 2008 Aug; 590(1-3):363-8. PubMed ID: 18614166
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation.
Pakala R; Pakala R; Benedict C
Lipids; 1999 Sep; 34(9):915-20. PubMed ID: 10574655
[TBL] [Abstract][Full Text] [Related]
10. Interspecies differences in thromboxane A2 receptors are distinguished by glibenclamide.
Kemp BK; McPherson GA
Eur J Pharmacol; 1998 Aug; 354(2-3):173-8. PubMed ID: 9754918
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological antagonism of Anchietia salutaris extracts on the contraction induced by prostaglandin D2 and U46619 in guinea-pig lung parenchymal strips.
Gambero A; Gomes JC
J Pharm Pharmacol; 1998 Nov; 50(11):1287-92. PubMed ID: 9877316
[TBL] [Abstract][Full Text] [Related]
12. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
13. Potentiating effects on contractions by purified baicalin and baicalein in the rat mesenteric artery.
Tsang SY; Chen ZY; Yao XQ; Huang Y
J Cardiovasc Pharmacol; 2000 Aug; 36(2):263-9. PubMed ID: 10942170
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
15. Difference in signal transduction mechanisms involved in 5-hydroxytryptamine- and U46619-induced vasoconstrictions.
Tasaki K; Hori M; Ozaki H; Karaki H; Wakabayashi I
J Smooth Muscle Res; 2003 Oct; 39(5):107-17. PubMed ID: 14695024
[TBL] [Abstract][Full Text] [Related]
16. Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Ishimura M; Kataoka S; Suda M; Maeda T; Hiyama Y
Allergol Int; 2006 Dec; 55(4):403-10. PubMed ID: 17130683
[TBL] [Abstract][Full Text] [Related]
17. Intracellular calcium and myosin light chain phosphorylation during U46619-activated vascular contraction.
Jiang MJ; Chan CF; Chang YL
Life Sci; 1994; 54(25):2005-13. PubMed ID: 7515455
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of n-6 and n-3 hydroxy fatty acids on thromboxane (U46619)-induced smooth muscle contraction.
Karanian JW; Kim HY; Salem N
J Pharmacol Exp Ther; 1994 Sep; 270(3):1105-9. PubMed ID: 7932158
[TBL] [Abstract][Full Text] [Related]
19. Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619.
Jannaway M; Torrens C; Warner JA; Sampson AP
Br J Pharmacol; 2018 Apr; 175(7):1100-1108. PubMed ID: 29352769
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological study on the enhancing effects of U46619 on guinea pig urinary bladder smooth muscle contraction induced by acetylcholine and α,β-methylene ATP and the possible involvement of protein kinase C.
Ou G; Komura A; Hojo M; Kato R; Ikeda M; Fujisawa M; Xu K; Yoshioka K; Obara K; Tanaka Y
J Pharmacol Sci; 2023 Nov; 153(3):119-129. PubMed ID: 37770153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
